These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation. Ji J, Fan H, Li F, Li X, Dong G, Gong W, Song Y, Liu F, Hua C, Tan R, Dou H, Hou Y. Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567 [Abstract] [Full Text] [Related]
3. Contrasting mechanisms of interferon-α inhibition by intravenous immunoglobulin after induction by immune complexes versus Toll-like receptor agonists. Wiedeman AE, Santer DM, Yan W, Miescher S, Käsermann F, Elkon KB. Arthritis Rheum; 2013 Oct; 65(10):2713-23. PubMed ID: 23840006 [Abstract] [Full Text] [Related]
4. Limited Effect of Indolamine 2,3-Dioxygenase Expression and Enzymatic Activity on Lupus-Like Disease in B6.Nba2 Mice. Davison LM, Liu JC, Huang L, Carroll TM, Mellor AL, Jørgensen TN. Front Immunol; 2019 Oct; 10():2017. PubMed ID: 31555267 [Abstract] [Full Text] [Related]
6. Phenotypic and functional alterations of pDCs in lupus-prone mice. Zhou Z, Ma J, Xiao C, Han X, Qiu R, Wang Y, Zhou Y, Wu L, Huang X, Shen N. Sci Rep; 2016 Feb 16; 6():20373. PubMed ID: 26879679 [Abstract] [Full Text] [Related]
7. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin. Wang H, Li T, Chen S, Gu Y, Ye S. Arthritis Rheumatol; 2015 Dec 16; 67(12):3190-200. PubMed ID: 26245802 [Abstract] [Full Text] [Related]
9. Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice. Jørgensen TN, Roper E, Thurman JM, Marrack P, Kotzin BL. Genes Immun; 2007 Dec 16; 8(8):653-62. PubMed ID: 17882225 [Abstract] [Full Text] [Related]
10. Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner. Liu Z, Bethunaickan R, Huang W, Lodhi U, Solano I, Madaio MP, Davidson A. Arthritis Rheum; 2011 Jan 16; 63(1):219-29. PubMed ID: 20954185 [Abstract] [Full Text] [Related]
11. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Blomberg S, Eloranta ML, Magnusson M, Alm GV, Rönnblom L. Arthritis Rheum; 2003 Sep 16; 48(9):2524-32. PubMed ID: 13130472 [Abstract] [Full Text] [Related]
12. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice. Jørgensen TN, Thurman J, Izui S, Falta MT, Metzger TE, Flannery SA, Kappler J, Marrack P, Kotzin BL. Genes Immun; 2006 Oct 16; 7(7):555-67. PubMed ID: 16900204 [Abstract] [Full Text] [Related]
13. IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus. Khoryati L, Augusto JF, Shipley E, Contin-Bordes C, Douchet I, Mitrovic S, Truchetet ME, Lazaro E, Duffau P, Couzi L, Jacquemin C, Barnetche T, Vacher P, Schaeverbeke T, Blanco P, Richez C, Fédération Hospitalo-Universitaire ACRONIM. Arthritis Rheumatol; 2016 Sep 16; 68(9):2221-31. PubMed ID: 26991804 [Abstract] [Full Text] [Related]
14. Ablation of SigH+ pDCs in B6.Nba2 mice prevents lupus-like disease development only if started before disease is fully established. Campbell NO, Davison LM, Banerjee S, Nguyen JK, Krafcik S, Silverman RH, Jorgensen TN. Lupus; 2022 Nov 16; 31(13):1619-1629. PubMed ID: 36134524 [Abstract] [Full Text] [Related]
15. Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent. Keller EJ, Dvorina N, Jørgensen TN. Int J Mol Sci; 2022 Jan 14; 23(2):. PubMed ID: 35055071 [Abstract] [Full Text] [Related]
16. B lymphocytes enhance interferon-α production by plasmacytoid dendritic cells. Berggren O, Hagberg N, Weber G, Alm GV, Rönnblom L, Eloranta ML. Arthritis Rheum; 2012 Oct 14; 64(10):3409-19. PubMed ID: 22736048 [Abstract] [Full Text] [Related]
17. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production. Zhang X, Lindwall E, Gauthier C, Lyman J, Spencer N, Alarakhia A, Fraser A, Ing S, Chen M, Webb-Detiege T, Zakem J, Davis W, Choi YS, Quinet R. Lupus; 2015 Aug 14; 24(9):909-17. PubMed ID: 25654980 [Abstract] [Full Text] [Related]
18. Dichotomous effects of complete versus partial class II major histocompatibility complex deficiency on circulating autoantibody levels in autoimmune-prone mice. Stohl W, Xu D, Metzger TE, Kim KS, Morel L, Kotzin BL. Arthritis Rheum; 2004 Jul 14; 50(7):2227-39. PubMed ID: 15248222 [Abstract] [Full Text] [Related]
19. Anti-interferon alpha treatment in SLE. Kirou KA, Gkrouzman E. Clin Immunol; 2013 Sep 14; 148(3):303-12. PubMed ID: 23566912 [Abstract] [Full Text] [Related]
20. Siglec-H-/- Plasmacytoid Dendritic Cells Protect Against Acute Liver Injury by Suppressing IFN-γ/Th1 Response and Promoting IL-21+ CD4 T Cells. Ahodantin J, Wu J, Funaki M, Flores J, Wang X, Zheng P, Liu Y, Su L. Cell Mol Gastroenterol Hepatol; 2024 Sep 14; 18(3):101367. PubMed ID: 38849082 [Abstract] [Full Text] [Related] Page: [Next] [New Search]